Munich Institute of Biomedical Engineering

The Munich Institute of Biomedical Engineering (MIBE) is an Integrative Research Institute (IRI) within the Technical University of Munich (TUM) that fosters interdisciplinary cooperation and synergies between researchers from the broad field of Biomedical Engineering.

About MIBE

At MIBE, researchers specializing in medicine, the natural sciences, and engineering join forces to develop new methods for preventing, diagnosing or treating diseases. The activities cover the entire development process – from the study of basic scientific principles through to their application in new medical devices, medicines and software. Beyond research, MIBE also provides educational opportunities for students and doctoral candidates and fosters entrepreneurship.

 

News

  • Oliver Lieleg, Professor of Biopolymer Materials at TUM, and his team develop mucin-based materials for medical applications.

    What mucins can do in medicine

    27 May 2024 | Oliver Lieleg, Professor of Biopolymer Materials at TUM, and his team develop mucin-based materials for medical applications such as coatings for contact lenses and intubation tubes.

  • Nuclei of HGPS cells

    “Can we delay age-related diseases?”

    29 February 2024 | Children with Hutchinson-Gilford Progeria Syndrome develop premature aging symptoms. Prof. Karima Djabali wants to understand the biological mechanisms behind these accelerated aging processes.

  • A team of researchers has made a significant advance in prime editing, the most versatile gene editing technology to date. They have developed a method for the targeted degradation of old DNA segments to make room for the insertion of new sequences. The illustration shows two hands and a drawn DNA double helix. One hand is erasing an old sequence, the other one is drawing the new one.

    Expanding the gene editing toolbox

    01 February 2024 | Researchers have made a significant advance in prime editing, the most versatile gene editing technology to date. They have developed a method for the targeted degradation of old DNA segments to make room for the insertion of new sequences.

Show all News